Securing Trust in the Global COVID-19 Supply Chain
Never has a secure and efficient global healthcare supply chain been more important than it is now.
As governments and businesses around the world face one of the most significant challenges in history – an unprecedented rapid mass development, distribution, and administration of Covid-19 vaccines – a new report issued by Deloitte points to universal adoption of global standards across the healthcare supply chain worldwide to enable fast, efficient, and safe distribution.
GS1 standards provide a global system of traceability built around globally identified products. This enables the ability to identify, capture and share the information needed about vaccines, medicine and medical devices for vaccine administration throughout the healthcare supply chain, accurately and efficiently.
The Deloitte study calls vaccine identification information (such as product identifier, lot number, and expiration date) “essential for healthcare providers to administer vaccines with confidence,” noting that, “the WHO recommends that all vaccines be identified with this data in a standardized barcode.”
GS1’s Executive Healthcare Dialogues brought together leaders from around the world to discuss key challenges, opportunities and provide practical information to successfully implement GS1 Standards in the pandemic context.
Watch all the Recordings
Roadmap to the Implementation of GS1 DataMatrix Barcodes on Pharmaceuticals in Canada.
The Global Supply Chain
GS1 standards make it possible to identify, capture and share information automatically and accurately about vaccines, PPE, medicine and medical devices relevant for vaccine administration and COVID-19 treatment moving through the healthcare supply chain.
Important stakeholders in the vaccine supply chain include pharmaceutical manufacturers, distributors, airlines, logistic providers and healthcare providers, including administration locations like long-term care facilities.
What's Different in the Vaccine Supply Chain?
The vaccine supply chain is often shorter, manufacturers deliver directly to administration locations.
There are requirements for ultra-cold storage. Therefore, some vaccines might only be able to be administered at specific locations.
Vaccine administration locations are not only the ‘typical’ healthcare providers but could also be long-term care facilities or vaccination centres.
Temporary exemption of regulatory requirements for identification and labelling of vaccines.
Benefits of GS1 Standards
For Vaccine Identification
For Vaccine Traceability
For Combatting Counterfeit COVID-19 Related Products
Key Supply Chain Stakeholders
Value for Government Regulators and Public Health Authorities
Value for Healthcare Providers
Value for Manufacturers
Value for Logistics Providers
Value for the Vaccine Recipient
GS1 Enables Healthcare's Digital Thread
GS1 identification keys enable vaccine and PPE traceability from supplier to recipient.